Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 57

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 2
Chunk 57
---
 the
effective date of an initial registration statement registering the resale of the shares of Common Stock, as issuable pursuant to
the SEPA, under the Securities Act of 1933, as amended (the “Securities Act”) or (ii) our receipt of the requisite
approval of our stockholders enabling us to issue shares of Common Stock to Yorkville under the SEPA, and upon conversion of the
Convertible Notes, collectively, in excess of the Exchange Cap (as defined below). In exchange, at the disbursement of the second
tranche, we anticipate that we will issue to Yorkville a second Convertible Note for the principal amount of $2.0 million, the
second Pre-Paid Advance, pursuant to the SEPA. Yorkville may convert all or any portion of the outstanding principal amount, accrued
and unpaid interest and other amounts outstanding under the Convertible Notes we issue it into shares of Common Stock, at any time
and from time to time during the term of the Convertible Notes. Under the applicable Nasdaq rules, in no event may we issue to
Yorkville under the SEPA or otherwise, including under conversion of the Convertible Notes, collectively more than 6,855,459 shares
of Common Stock, which number of shares is equal to 19.99% of the shares of Common Stock outstanding immediately prior to the
execution of the SEPA (the “Exchange Cap”), unless we receive the requisite stockholder approval to issue shares of
Common Stock in excess thereof in accordance with applicable Nasdaq rules.

Under
the SEPA, we also have the right to sell to Yorkville an additional $14.0 million of our Common Stock in the form of one or more advances
(the “Advances”), subject to certain limitations and conditions. Sales of our shares of Common Stock to Yorkville as Advances
under the SEPA, and the timing of any such sales, are at our complete discretion and we are under no obligation to sell any shares of
Common Stock to Yorkville under the SEPA.

The
price of our Common Stock could decline if there are substantial sales of shares of our Common Stock, if there is a large number of shares
of our Common Stock available for sale, or if there is the perception that these sales could occur.

Any
issuance of shares of Common Stock pursuant to the SEPA, if not terminated and if and when available, whether upon conversion by Yorkville
of a Convertible Note or upon issuance of common shares in